| View |
|
DRP-13738
|
Folic Acid (Vitamin B9)
|
Apfolic
|
5 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2025
|
| View |
|
DRP-13742
|
Ferrous fumarate+ Folic Acid (Vitamin B9)
|
Feromate Plus Tab
|
181.82 mg (equivalent to 60 mg elemental Iron)/
400 mcg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRP-13740
|
Ferrous fumarate+ Folic Acid (Vitamin B9)
|
Feromate Plus Cap
|
181.82 mg (equivalent to 60 mg elemental Iron)/
400 mcg
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRP-13748
|
Paracetamol
|
None
|
500 mg
|
Tablet
|
Analgesic/ Antipyretic
|
Medico Remedies Limited
|
India
|
Initial
|
04 April 2023
|
04 April 2028
|
| View |
|
DRP-13735
|
Pantoprazole (as sodium sesquihydrate) +
Domperidone
|
Panto-Plus
|
Formulation:
Each modified release capsule contains:
*As enteric-coated pellets:
Pantoprazole (as sodium sesquihydrate) .......... 40 mg
*As sustained-release pellets
Domperidone ………….30 mg
|
Modified Release Capsule
|
-
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRP-13722
|
Methylergometrine maleate
|
Saphgometrine
|
125 mcg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
31 March 2023
|
31 March 2028
|
| View |
|
DRP-13715
|
Methyldopa
|
Aldopiem
|
250 mg
|
Film-Coated Tablet
|
-
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
31 March 2023
|
31 March 2028
|
| View |
|
DRP-13381
|
Co-Amoxiclav
|
Elmox-CV 375
|
375 mg
|
Film-Coated Tablet
|
-
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial (Reapplication)
|
03 April 2023
|
03 April 2028
|
| View |
|
BRP-123
|
Bevacizumab
|
Bonmab
|
400 mg/16 mL (25 mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
-
|
Joint Stock Company Biocad
|
Russia
|
Initial (Re-Application)
|
03 April 2023
|
03 April 2028
|
| View |
|
BRP-122
|
Bevacizumab
|
Bonmab
|
100 mg/4 mL (25 mg/ mL)
|
Concentrate for Solution for
Infusion (IV)
|
-
|
Joint Stock Company Biocad
|
Russia
|
Initial (Re-Application)
|
03 April 2023
|
03 April 2028
|
| View |
|
DRP-13727
|
Rosuvastatin (as calcium)
|
Vestflo-10
|
10mg
|
Film-Coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
04 April 2023
|
04 April 2028
|
| View |
|
DRHR-2233
|
Peppermint Oil+ Eucalyptus Oil+ Methyl Salicylate + Camphor
|
Katinko Peppermint Oil
|
Formulation:
Each 100 mL contains:
Peppermint Oil 11.5 g
Eucalyptus Oil Methyl 2 g Salicylate 28
Camphor 1 g
|
Liniment
|
-
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRHR-2236
|
Peppermint Oil+ Eucalyptus Oil+ Methyl Salicylate + Camphor
|
Katinko Peppermint Oil
|
Formulation:
Each 100 mL contains:
Peppermint Oil 11.5 g
Eucalyptus Oil 2 g
Methyl Salicylate 2 g Camphor 1 g
|
Liniment
|
-
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRHR-2234
|
Peppermint Oil + Methyl Salicylate + Camphor
|
Katinko Peppermint
|
Formulation:
Each 100 g contains:
Peppermint Oil 10.5 g
Methyl Salicylate 1 g
Camphor 0.5 g
|
Ointment
|
-
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRHR-2235
|
Peppermint Oil + Methyl Salicylate + Camphor
|
Katinko Peppermint
|
Formulation:
Each 100 g contains:
Peppermint Oil 10.5 g
Methyl Salicylate 1 g
Camphor 0.5 g
|
Ointment Stick
|
-
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
04 April 2023
|
04 April 2028
|
| View |
|
DRP-13728
|
Rivaroxaban
|
Roxavid
|
20 mg
|
Film-Coated Tablet
|
-
|
Inventia Healthcare Limited
|
India
|
Initial
|
31 March 2023
|
31 March 2028
|
| View |
|
DRP-13736
|
Propofol
|
Saphprofol
|
10 mg/mL (1% w/v)
|
Emulsion for Injection (IV)
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DR-XY48689
|
Rivaroxaban
|
Ixobran 10
|
10 mg
|
Film-Coated Tablet
|
-
|
Inventia Healthcare Limited
|
India
|
Initial
|
03 April 2023
|
03 April 2028
|
| View |
|
DRP-4387-01
|
Irbesartan
|
Arten 300
|
300 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor Blocker
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
Renewal
|
29 April 2023
|
29 April 2028
|
| View |
|
DRP-13767
|
Bacitracin + Polymyxin B Sulfate + Neomycin
|
Saphtracin-B
|
200 IU/4000 IU/3 mg per g
|
Ointment
|
-
|
Azine Healthcare Pvt. Ltd
|
India
|
Initial [OTC]
|
19 April 2023
|
19 April 2028
|